We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STWD icon
701
Starwood Property Trust
STWD
$6.17B
$18.7M 0.02%
1,018,626
-66,374
-6% -$1.32M
INDA icon
702
iShares MSCI India ETF
INDA
$6.6B
$18.7M 0.02%
447,128
-205,516
-31% -$8.7M
WEX icon
703
WEX
WEX
$6.44B
$18.6M 0.02%
113,407
+66,094
+140% +$10.3M
SMH icon
704
VanEck Semiconductor ETF
SMH
$70.6B
$18.5M 0.02%
182,622
+2,972
+2% +$302K
OTIS icon
705
Otis Worldwide
OTIS
$27.8B
$18.5M 0.02%
236,169
-61,074
-21% -$4.51M
TTWO icon
706
Take-Two Interactive
TTWO
$46.8B
$18.4M 0.02%
177,012
-6,373
-3% -$690K
GDV icon
707
Gabelli Dividend & Income Trust
GDV
$2.67B
$18.4M 0.02%
893,801
-607
-0.1% -$12.4K
MMP
708
DELISTED
Magellan Midstream Partners, L.P.
MMP
$18.4M 0.02%
366,799
-119,700
-25% -$6.07M
KMX icon
709
CarMax
KMX
$8.26B
$18.4M 0.02%
302,253
+141,725
+88% +$9.1M
BNY
710
Bank of New York Mellon
BNY
$109B
$18.4M 0.02%
404,292
-3,264
-0.8% -$140K
PCH
711
DELISTED
PotlatchDeltic
PCH
$18.3M 0.02%
416,122
+7,635
+2% +$345K
ADC icon
712
Agree Realty
ADC
$9.13B
$18.2M 0.02%
257,253
-3,334
-1% -$229K
MLPA icon
713
Global X MLP ETF
MLPA
$2.28B
$18.1M 0.02%
439,387
+201,112
+84% +$8.43M
HR icon
714
Healthcare Realty
HR
$6.56B
$18.1M 0.02%
940,873
+93,320
+11% +$1.83M
TRGP icon
715
Targa Resources
TRGP
$56.9B
$18.1M 0.02%
246,390
-4,932
-2% -$344K
SCHM icon
716
Schwab US Mid-Cap ETF
SCHM
$15.1B
$18M 0.02%
824,286
-1,350
-0.2% -$29.6K
MGA icon
717
Magna International
MGA
$18.8B
$18M 0.02%
320,836
+61,901
+24% +$3.48M
THQ
718
abrdn Healthcare Opportunities Fund
THQ
$810M
$18M 0.02%
909,015
+10,597
+1% +$209K
LDOS icon
719
Leidos
LDOS
$17.7B
$18M 0.02%
171,071
+25,599
+18% +$2.62M
OLN icon
720
Olin
OLN
$2.17B
$18M 0.02%
339,527
+20,002
+6% +$1.06M
JBL icon
721
Jabil
JBL
$37.4B
$17.9M 0.02%
262,065
+33,667
+15% +$2.23M
HOLX
722
DELISTED
Hologic
HOLX
$17.9M 0.02%
238,868
-30,778
-11% -$2.19M
WPM icon
723
Wheaton Precious Metals
WPM
$61B
$17.7M 0.02%
452,805
+27,541
+6% +$996K
OIH icon
724
VanEck Oil Services ETF
OIH
$1.97B
$17.7M 0.02%
58,120
-1,302
-2% -$373K
SJNK icon
725
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.79B
$17.7M 0.02%
728,654
-19,585
-3% -$476K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.